222 related articles for article (PubMed ID: 38028758)
1. Not all kidney cysts are created equal: a distinct renal cystogenic mechanism in tuberous sclerosis complex (TSC).
Soleimani M
Front Physiol; 2023; 14():1289388. PubMed ID: 38028758
[TBL] [Abstract][Full Text] [Related]
2. Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex.
Barone S; Zahedi K; Brooks M; Henske EP; Yang Y; Zhang E; Bissler JJ; Yu JJ; Soleimani M
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536341
[TBL] [Abstract][Full Text] [Related]
3. Carbonic Anhydrase 2 Deletion Delays the Growth of Kidney Cysts Whereas Foxi1 Deletion Completely Abrogates Cystogenesis in TSC.
Barone S; Zahedi K; Brooks M; Soleimani M
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731991
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Electrogenic 2Cl
Barone S; Brooks M; Zahedi K; Holliday LS; Bissler J; Yu JJ; Soleimani M
Am J Pathol; 2023 Feb; 193(2):191-200. PubMed ID: 36336066
[TBL] [Abstract][Full Text] [Related]
5. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
6. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
Lam HC; Siroky BJ; Henske EP
Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
[TBL] [Abstract][Full Text] [Related]
7. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
[TBL] [Abstract][Full Text] [Related]
8. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.
Zhou J; Brugarolas J; Parada LF
Hum Mol Genet; 2009 Nov; 18(22):4428-41. PubMed ID: 19692352
[TBL] [Abstract][Full Text] [Related]
9. A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease.
Longa L; Scolari F; Brusco A; Carbonara C; Polidoro S; Valzorio B; Riegler P; Migone N; Maiorca R
Nephrol Dial Transplant; 1997 Sep; 12(9):1900-7. PubMed ID: 9306341
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
11. Renal Transcriptome and Metabolome in Mice with Principal Cell-Specific Ablation of the Tsc1 Gene: Derangements in Pathways Associated with Cell Metabolism, Growth and Acid Secretion.
Zahedi K; Barone S; Brooks M; Murray Stewart T; Casero RA; Soleimani M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142537
[TBL] [Abstract][Full Text] [Related]
12. Cystic kidney disease in tuberous sclerosis complex: current knowledge and unresolved questions.
Gallo-Bernal S; Kilcoyne A; Gee MS; Paul E
Pediatr Nephrol; 2023 Oct; 38(10):3253-3264. PubMed ID: 36445479
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
14. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
[TBL] [Abstract][Full Text] [Related]
15. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
16. Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes.
Pietrobon A; Yockell-Lelièvre J; Flood TA; Stanford WL
Cell Rep; 2022 Jul; 40(1):111048. PubMed ID: 35793620
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
[TBL] [Abstract][Full Text] [Related]
18. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
19. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]